- Home
- ONL vs SEER Comparison
ONL vs SEER Comparison
Compare ONL & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONL
- SEER
- Stock Information
- Founded
- ONL 2021
- SEER 2017
- Country
- ONL United States
- SEER United States
- Employees
- ONL N/A
- SEER N/A
- Industry
- ONL Real Estate Investment Trusts
- SEER Medicinal Chemicals and Botanical Products
- Sector
- ONL Real Estate
- SEER Health Care
- Exchange
- ONL Nasdaq
- SEER Nasdaq
- Market Cap
- ONL 119.7M
- SEER 125.3M
- IPO Year
- ONL N/A
- SEER 2020
- Fundamental
- Price
- ONL $2.55
- SEER $2.12
- Analyst Decision
- ONL Hold
- SEER Hold
- Analyst Count
- ONL 1
- SEER 1
- Target Price
- ONL N/A
- SEER $3.00
- AVG Volume (30 Days)
- ONL 370.5K
- SEER 86.8K
- Earning Date
- ONL 08-06-2025
- SEER 08-06-2025
- Dividend Yield
- ONL 3.13%
- SEER N/A
- EPS Growth
- ONL N/A
- SEER N/A
- EPS
- ONL N/A
- SEER N/A
- Revenue
- ONL $154,796,000.00
- SEER $15,309,000.00
- Revenue This Year
- ONL N/A
- SEER $27.05
- Revenue Next Year
- ONL N/A
- SEER $28.33
- P/E Ratio
- ONL N/A
- SEER N/A
- Revenue Growth
- ONL N/A
- SEER N/A
- 52 Week Low
- ONL $1.46
- SEER $1.59
- 52 Week High
- ONL $4.39
- SEER $2.63
- Technical
- Relative Strength Index (RSI)
- ONL 54.98
- SEER 47.68
- Support Level
- ONL $2.51
- SEER $2.08
- Resistance Level
- ONL $2.72
- SEER $2.25
- Average True Range (ATR)
- ONL 0.12
- SEER 0.06
- MACD
- ONL -0.02
- SEER -0.01
- Stochastic Oscillator
- ONL 37.14
- SEER 25.71
About ONL Orion Office REIT Inc.
Orion Properties Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased on a single-tenant net lease basis to creditworthy clients. The portfolio of the company includes traditional office buildings, governmental offices, medical offices, laboratories, and others. The Company operates in one business segment: direct ownership and operation of commercial real estate.
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.